Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 42 | 2025 | 803 | 13.400 |
Why?
|
| Apolipoprotein E4 | 17 | 2025 | 184 | 6.620 |
Why?
|
| Alzheimer Disease | 23 | 2025 | 1406 | 5.580 |
Why?
|
| Aged | 82 | 2025 | 7638 | 3.710 |
Why?
|
| Cognition | 30 | 2024 | 1025 | 3.530 |
Why?
|
| Female | 88 | 2025 | 13117 | 2.890 |
Why?
|
| tau Proteins | 6 | 2025 | 153 | 2.850 |
Why?
|
| Male | 78 | 2025 | 12636 | 2.770 |
Why?
|
| Chicago | 29 | 2025 | 847 | 2.770 |
Why?
|
| Cognition Disorders | 14 | 2018 | 724 | 2.760 |
Why?
|
| Neurofilament Proteins | 4 | 2025 | 17 | 2.630 |
Why?
|
| Humans | 105 | 2025 | 23156 | 2.590 |
Why?
|
| Aged, 80 and over | 41 | 2025 | 3857 | 2.510 |
Why?
|
| Stroke | 6 | 2023 | 243 | 2.410 |
Why?
|
| Longitudinal Studies | 28 | 2025 | 1103 | 2.340 |
Why?
|
| Aging | 14 | 2025 | 1175 | 2.330 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 98 | 2.320 |
Why?
|
| Cohort Studies | 25 | 2025 | 1463 | 2.150 |
Why?
|
| Biomarkers | 11 | 2025 | 481 | 2.000 |
Why?
|
| Risk Factors | 25 | 2025 | 2019 | 1.920 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 160 | 1.790 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2025 | 39 | 1.750 |
Why?
|
| Alleles | 9 | 2024 | 172 | 1.720 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 368 | 1.610 |
Why?
|
| Blood Pressure | 3 | 2024 | 171 | 1.500 |
Why?
|
| Exercise | 9 | 2023 | 404 | 1.500 |
Why?
|
| White Matter | 3 | 2022 | 113 | 1.460 |
Why?
|
| Prospective Studies | 15 | 2025 | 1511 | 1.390 |
Why?
|
| Dementia | 9 | 2024 | 415 | 1.330 |
Why?
|
| Population Surveillance | 3 | 2021 | 105 | 1.320 |
Why?
|
| Vitamin E | 2 | 2023 | 38 | 1.170 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 19 | 1.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 295 | 1.140 |
Why?
|
| Genotype | 7 | 2024 | 265 | 1.130 |
Why?
|
| Incidence | 12 | 2025 | 631 | 1.130 |
Why?
|
| Disease Progression | 11 | 2019 | 543 | 1.080 |
Why?
|
| Memory Disorders | 3 | 2024 | 115 | 1.080 |
Why?
|
| Loneliness | 2 | 2025 | 45 | 1.040 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 26 | 1.040 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 72 | 1.020 |
Why?
|
| Mortality | 4 | 2021 | 76 | 0.980 |
Why?
|
| United States | 12 | 2024 | 1796 | 0.880 |
Why?
|
| Lipids | 1 | 2025 | 46 | 0.880 |
Why?
|
| Social Isolation | 1 | 2025 | 22 | 0.880 |
Why?
|
| Disability Evaluation | 4 | 2014 | 225 | 0.860 |
Why?
|
| Dietary Fats | 1 | 2024 | 37 | 0.830 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.820 |
Why?
|
| Depression | 4 | 2014 | 383 | 0.790 |
Why?
|
| Neuropathology | 3 | 2021 | 63 | 0.780 |
Why?
|
| Vitamin D | 1 | 2022 | 28 | 0.740 |
Why?
|
| Healthy Lifestyle | 5 | 2024 | 39 | 0.730 |
Why?
|
| Independent Living | 5 | 2025 | 240 | 0.710 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 42 | 0.710 |
Why?
|
| Membrane Proteins | 1 | 2021 | 140 | 0.650 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 1430 | 0.640 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 171 | 0.630 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 916 | 0.600 |
Why?
|
| Time Factors | 10 | 2021 | 1264 | 0.570 |
Why?
|
| Diet | 4 | 2023 | 181 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 277 | 0.530 |
Why?
|
| Art | 1 | 2016 | 1 | 0.510 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 46 | 0.500 |
Why?
|
| Music | 1 | 2016 | 20 | 0.500 |
Why?
|
| Diabetes Complications | 1 | 2016 | 47 | 0.490 |
Why?
|
| Models, Statistical | 2 | 2021 | 116 | 0.480 |
Why?
|
| Life Style | 5 | 2022 | 167 | 0.480 |
Why?
|
| Prevalence | 3 | 2023 | 380 | 0.470 |
Why?
|
| Obesity | 6 | 2014 | 288 | 0.460 |
Why?
|
| Body Mass Index | 6 | 2018 | 381 | 0.450 |
Why?
|
| Cognitive Aging | 4 | 2021 | 64 | 0.450 |
Why?
|
| Mobility Limitation | 2 | 2015 | 78 | 0.450 |
Why?
|
| Depressive Disorder | 1 | 2015 | 163 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 150 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 160 | 0.430 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 176 | 0.420 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 13 | 0.420 |
Why?
|
| Dopamine Agents | 1 | 2014 | 11 | 0.410 |
Why?
|
| Memantine | 1 | 2014 | 8 | 0.410 |
Why?
|
| Motor Activity | 2 | 2015 | 274 | 0.410 |
Why?
|
| Antioxidants | 1 | 2014 | 56 | 0.400 |
Why?
|
| Memory, Episodic | 3 | 2018 | 81 | 0.380 |
Why?
|
| Health Status Disparities | 1 | 2013 | 66 | 0.380 |
Why?
|
| Diagnosis | 1 | 2011 | 18 | 0.360 |
Why?
|
| Medical Informatics | 1 | 2011 | 8 | 0.360 |
Why?
|
| Area Under Curve | 1 | 2011 | 58 | 0.360 |
Why?
|
| Linear Models | 3 | 2016 | 202 | 0.340 |
Why?
|
| Disabled Persons | 1 | 2012 | 89 | 0.330 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.330 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 437 | 0.330 |
Why?
|
| Middle Aged | 21 | 2019 | 7964 | 0.300 |
Why?
|
| Age of Onset | 3 | 2014 | 74 | 0.290 |
Why?
|
| Genetic Loci | 3 | 2018 | 31 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 871 | 0.270 |
Why?
|
| Postmenopause | 7 | 2006 | 57 | 0.260 |
Why?
|
| Hypertension | 2 | 2024 | 169 | 0.240 |
Why?
|
| Triglycerides | 2 | 2025 | 54 | 0.240 |
Why?
|
| Neuroticism | 2 | 2023 | 23 | 0.230 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 36 | 0.220 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 210 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Cholesterol | 1 | 2025 | 57 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 14 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 18 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 16 | 0.220 |
Why?
|
| Survivors | 3 | 2022 | 69 | 0.220 |
Why?
|
| Adult | 11 | 2023 | 6942 | 0.220 |
Why?
|
| Heterozygote | 1 | 2025 | 90 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 399 | 0.200 |
Why?
|
| Risk Assessment | 2 | 2024 | 550 | 0.200 |
Why?
|
| Florida | 1 | 2023 | 15 | 0.200 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.190 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 12 | 0.190 |
Why?
|
| Regression Analysis | 4 | 2011 | 215 | 0.190 |
Why?
|
| Flavonols | 1 | 2022 | 6 | 0.190 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 6 | 0.190 |
Why?
|
| Age Factors | 2 | 2022 | 650 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 15 | 0.190 |
Why?
|
| Brain Infarction | 1 | 2023 | 63 | 0.190 |
Why?
|
| Brain | 4 | 2024 | 1241 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2022 | 55 | 0.180 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 24 | 0.180 |
Why?
|
| Life Expectancy | 1 | 2022 | 22 | 0.180 |
Why?
|
| Stress, Psychological | 2 | 2014 | 215 | 0.180 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 3 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 34 | 0.170 |
Why?
|
| Cost of Illness | 1 | 2021 | 44 | 0.170 |
Why?
|
| Noise | 1 | 2020 | 24 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2020 | 51 | 0.160 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 72 | 0.160 |
Why?
|
| Neuroimaging | 1 | 2020 | 105 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 170 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 128 | 0.150 |
Why?
|
| Residence Characteristics | 1 | 2020 | 179 | 0.150 |
Why?
|
| Confidence Intervals | 2 | 2017 | 77 | 0.150 |
Why?
|
| Hippocampus | 1 | 2020 | 196 | 0.150 |
Why?
|
| Phototherapy | 1 | 2019 | 27 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 8 | 0.150 |
Why?
|
| Social Networking | 1 | 2018 | 9 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2018 | 13 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2017 | 227 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2016 | 112 | 0.140 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 12 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 25 | 0.140 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 1036 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 269 | 0.140 |
Why?
|
| Nursing Homes | 1 | 2018 | 41 | 0.140 |
Why?
|
| Parkinson Disease | 2 | 2022 | 595 | 0.140 |
Why?
|
| Social Environment | 1 | 2018 | 71 | 0.130 |
Why?
|
| Pain Management | 1 | 2019 | 126 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 58 | 0.130 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.130 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2019 | 129 | 0.130 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.130 |
Why?
|
| Prebiotics | 1 | 2017 | 18 | 0.130 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mucormycosis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 11 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2017 | 14 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 230 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.130 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.130 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 112 | 0.130 |
Why?
|
| Reproduction | 1 | 2016 | 9 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 26 | 0.130 |
Why?
|
| Warfare | 1 | 2016 | 12 | 0.130 |
Why?
|
| Terrorism | 1 | 2016 | 9 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2014 | 39 | 0.120 |
Why?
|
| Reading | 1 | 2016 | 28 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2015 | 189 | 0.120 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 6 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 66 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 202 | 0.110 |
Why?
|
| Insulin | 2 | 2014 | 77 | 0.110 |
Why?
|
| Health Status | 2 | 2014 | 204 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2015 | 4 | 0.110 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 10 | 0.110 |
Why?
|
| Urinalysis | 1 | 2015 | 7 | 0.110 |
Why?
|
| Rhinitis | 1 | 2017 | 136 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2014 | 104 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2005 | 73 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 164 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 32 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 53 | 0.110 |
Why?
|
| Sinusitis | 1 | 2017 | 151 | 0.110 |
Why?
|
| Hospitalization | 2 | 2014 | 287 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 60 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 84 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 13 | 0.100 |
Why?
|
| Cats | 1 | 2014 | 28 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2014 | 12 | 0.100 |
Why?
|
| Medicare | 1 | 2014 | 108 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2014 | 61 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 279 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 220 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 57 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 203 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 157 | 0.100 |
Why?
|
| Mindfulness | 1 | 2014 | 46 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 273 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 310 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2015 | 93 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 107 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 131 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 180 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2013 | 73 | 0.090 |
Why?
|
| Adenoma | 1 | 2013 | 58 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 40 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 375 | 0.090 |
Why?
|
| Gait | 1 | 2015 | 384 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 34 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 107 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 121 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 34 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 92 | 0.080 |
Why?
|
| Frail Elderly | 1 | 2010 | 37 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 86 | 0.080 |
Why?
|
| Testosterone | 3 | 2004 | 27 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 564 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 173 | 0.080 |
Why?
|
| Algorithms | 1 | 2010 | 304 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 444 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 1654 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 5 | 0.060 |
Why?
|
| Animals | 1 | 2014 | 3270 | 0.060 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 93 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 369 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 260 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 80 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 37 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 83 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 37 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Copper | 1 | 2024 | 15 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 12 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 91 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2017 | 374 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 39 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2004 | 4 | 0.050 |
Why?
|
| Androgens | 1 | 2004 | 7 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.050 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 162 | 0.050 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 55 | 0.050 |
Why?
|
| Estrogens | 1 | 2004 | 26 | 0.050 |
Why?
|
| Parents | 1 | 2005 | 107 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 775 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 6 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 7 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 47 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 81 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 12 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 356 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2021 | 24 | 0.040 |
Why?
|
| Washington | 3 | 2006 | 4 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 65 | 0.040 |
Why?
|
| Tremor | 1 | 2022 | 94 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 260 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 223 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 65 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1160 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 163 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 37 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 46 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 15 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 1883 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 8 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 20 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 40 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 42 | 0.030 |
Why?
|
| Alanine | 1 | 2018 | 12 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2018 | 14 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 99 | 0.030 |
Why?
|
| Educational Status | 1 | 2018 | 223 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 135 | 0.030 |
Why?
|
| Veterans | 1 | 2019 | 87 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 16 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2019 | 127 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 26 | 0.030 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.030 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.030 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 41 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 485 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 13 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 42 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 8 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 17 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 4 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 32 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 11 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 270 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 13 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 8 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 163 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 40 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 213 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 2989 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 324 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 166 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 18 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 124 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 27 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 179 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 37 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 6 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 13 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 23 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 31 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 29 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 94 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 174 | 0.030 |
Why?
|
| China | 1 | 2014 | 45 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 129 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 91 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 21 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 58 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 8 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 29 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 16 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 521 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 52 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 171 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 34 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 535 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 146 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 101 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 125 | 0.020 |
Why?
|
| Critical Illness | 1 | 2014 | 98 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 564 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 100 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 234 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 297 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 66 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 166 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 295 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 11 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 13 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 184 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 192 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 804 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 9 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 23 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 40 | 0.010 |
Why?
|
| Leptin | 1 | 2005 | 18 | 0.010 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.010 |
Why?
|
| Body Size | 1 | 2004 | 6 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 65 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 48 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 66 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 19 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 77 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 26 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 48 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 62 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 29 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 86 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 353 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 576 | 0.010 |
Why?
|